Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell CarcinomaEduard Roussel, Maarten Albersen, Matthias Heck et al.|European Urology Oncology|2020Cited by 50
Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC RegistryMargaret Meagher, Ithaar Derweesh, Maria Carmen Mir et al.|Clinical Genitourinary Cancer|2022Cited by 21
Impact of metastasectomy on cancer specific and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registryMargaret Meagher, Ithaar Derweesh, M.C. Mir et al.|European Urology Open Science|2020Cited by 2
Minimally invasive versus open cytoreductive nephrectomy for primary metastatic renal cancer: A multi-institutional experience from the REMARCC registryRiccardo Campi, Maria Carmen Mir, Michele Marchioni et al.|European Urology Open Science|2020Cited by 1
Proposal for a two-tier re-classification of stage IV/M1 renal cell carcinoma into M1 (oligometastatic) and M2 (polymetastatic) sub stagesMargaret Meagher, Ithaar Derweesh, Mujahid Ahmad Mir et al.|European Urology Open Science|2020Cited by 0